SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Concord Biotech - Quaterly Results

13 Feb 2025 Evaluate
The Total revenue for the quarter ended December 2024 of  Rs. 2442.20 millions remain, more or less, the same.A slender decline of -0.62% was recorded to Rs. 740.90  millions from Rs. 745.54 millions in the corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 1126.82 millions from 1141.17 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 2442.20 2407.96 1.42 7702.03 6979.70 10.35 10169.39 8531.68 19.20
Other Income 147.29 81.87 79.91 350.63 229.67 52.67 337.80 353.09 -4.33
PBIDT 1126.82 1141.17 -1.26 3509.72 3202.39 9.60 4653.37 3785.96 22.91
Interest 0.97 4.95 -80.40 4.34 20.89 -79.22 25.52 45.10 -43.41
PBDT 1125.85 1136.22 -0.91 3505.38 3181.50 10.18 4627.85 3740.86 23.71
Depreciation 132.64 135.37 -2.02 397.56 398.73 -0.29 535.92 540.32 -0.81
PBT 993.21 1000.85 -0.76 3107.82 2782.77 11.68 4091.93 3200.54 27.85
TAX 252.31 255.31 -1.18 797.53 707.58 12.71 1044.62 819.28 27.50
Deferred Tax 15.39 -2.69 -672.12 26.08 9.02 189.14 46.28 23.82 94.29
PAT 740.90 745.54 -0.62 2310.29 2075.19 11.33 3047.31 2381.26 27.97
Equity 104.62 104.62 0.00 104.62 104.62 0.00 104.62 104.62 0.00
PBIDTM(%) 46.14 47.39 -2.64 45.57 45.88 -0.68 45.76 44.38 3.12

Concord Biotech Share Price

1067.40 -13.85 (-1.28%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×